文献速递乳腺技术与安全乳腺X线

COVID-19大流行后长期乳腺X线筛查趋势及回归筛查的预测因素:全州登记研究结果

Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
PubMed 文献 · Radiol Imaging Cancer · 2024-01-01

该回顾性研究基于佛蒙特州乳腺X线筛查登记数据(222 384名40岁及以上女性),分析2000-2022年筛查趋势及COVID-19后回归筛查的预测因素。2019年筛查比例61.3%降至2021年56.0%,2022年回升至60.7%,仍低于2007-2010年峰值66.1%-67.0%;2010-2022年年均变化-1.1%。年龄40-44岁vs 60-64岁RR=0.94,黑种人vs白种人RR=0.84,高中以下vs大学学历RR=0.84,乳腺癌5年风险极高vs平均RR=1.06。

要点

  • 2022年筛查率60.7%,仍低于2007-2010年峰值66.1%-67.0%。
  • 2010-2022年筛查率年均下降1.1%(95%CI:-1.5%,-0.8%)。
  • 年轻、黑种人、低学历女性大流行后回归筛查概率较低。

核心结论

  • 尽管2022年筛查率回升至接近大流行前水平,但佛蒙特州乳腺X线筛查率自2010年以来持续下降,部分社会人口学群体大流行后回归筛查的可能性较低。

研究设计与样本

  • 回顾性研究,纳入佛蒙特州乳腺癌症监测系统222 384名40岁及以上女性(平均年龄58.8岁±11.7),分析2000-2022年筛查数据;另对2018年1月至2020年3月筛查的95 644人队列分析2020-2022年回归筛查情况。

诊断标准与关键数值

  • 年龄40-44岁 vs 60-64岁回归筛查风险比RR=0.94(95%CI:0.93,0.95)。
  • 黑种人 vs 白种人回归筛查风险比RR=0.84(95%CI:0.78,0.90)。
  • 高中以下学历 vs 大学学历回归筛查风险比RR=0.84(95%CI:0.81,0.86)。
  • 乳腺癌5年风险极高 vs 平均风险回归筛查风险比RR=1.06(95%CI:1.04,1.08)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate long-term trends in mammography screening rates and identify sociodemographic and breast cancer risk characteristics associated with return to screening after the COVID-19 pandemic. Materials and Methods In this retrospective study, statewide screening mammography data of 222 384 female individuals aged 40 years or older (mean age, 58.8 years ± 11.7 [SD]) from the Vermont Breast Cancer Surveillance System were evaluated to generate descriptive statistics and Joinpoint models to characterize screening patterns during 2000-2022. Log-binomial regression models estimated associations of sociodemographic and risk characteristics with post-COVID-19 pandemic return to screening. Results The proportion of female individuals in Vermont aged 50-74 years with a screening mammogram obtained in the previous 2 years declined from a prepandemic level of 61.3% (95% CI: 61.1%, 61.6%) in 2019 to 56.0% (95% CI: 55.7%, 56.3%) in 2021 before rebounding to 60.7% (95% CI: 60.4%, 61.0%) in 2022. Screening adherence in 2022 remained substantially lower than that observed during the 2007-2010 apex of screening adherence (66.1%-67.0%). Joinpoint models estimated an annual percent change of -1.1% (95% CI: -1.5%, -0.8%) during 2010-2022. Among the cohort of 95 644 individuals screened during January 2018-March 2020, the probability of returning to screening during 2020-2022 varied by age (eg, risk ratio [RR] = 0.94 [95% CI: 0.93, 0.95] for age 40-44 vs age 60-64 years), race and ethnicity (RR = 0.84 [95% CI: 0.78, 0.90] for Black vs White individuals), education (RR = 0.84 [95% CI: 0.81, 0.86] for less than high school degree vs college degree), and by 5-year breast cancer risk (RR = 1.06 [95% CI: 1.04, 1.08] for very high vs average risk). Conclusion Despite a rebound to near prepandemic levels, Vermont mammography screening rates have steadily declined since 2010, with certain sociodemographic groups less likely to return to screening after the pandemic. Keywords: Mammography, Breast, Health Policy and Practice, Neoplasms-Primary, Epidemiology, Screening Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Sprague BL, Nowak SA, Ahern TP, et al. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry. Radiol Imaging Cancer. 2024. PMID: 38578209. doi:10.1148/rycan.230161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。